Status:
COMPLETED
Effects of RME on Engagement in Buprenorphine Treatment
Lead Sponsor:
Cambridge Health Alliance
Collaborating Sponsors:
University of South Florida
Centers for Disease Control and Prevention
Conditions:
Opioid Use Disorder
Behavioral Symptoms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will conduct a Randomized Controlled Trial (RCT) comparing the Remote Motivational Enhancement (RME) coaching sessions + MindWell screenings arm to an Information-only + MindWell scr...
Detailed Description
In an effort to assess and address patients' mental health needs, Cambridge Health Alliance has developed an innovative screening program (MindWell) using electronic computerized adaptive testing that...
Eligibility Criteria
Inclusion
- Age 18 or older
- Meets DSM-IV criteria for opioid dependence or DSM-V criteria for opioid use disorder
- Current patient enrolled in Bicycle Health's buprenorphine treatment program
- Ability to provide informed consent
- Access to the internet and an electronic device to attend remote coaching sessions via videoconferencing and complete online assessments
- Sufficient English fluency to understand study procedures and assessments
- Completion of the CAT-MH screening modules, BAM, and PSS measures (through CHAMindWell and Bicycle Health's service implementation project)
Exclusion
- Non-English speaking
- Reporting active homicidal or suicidal ideation
- Exhibits signs of active mania or psychosis
- Expected incarceration in next 12 weeks (those that are incarcerated during the study will be withdrawn from the study)
- Prisoners
- Unable or unwilling to use a mobile device
- Has a medical contraindication to BUP
- Unable to complete screening and baseline assessments
- Unstable medical illness that could lead to an expected hospitalization in the next 12 weeks
- Third-trimester pregnancy (if a pregnant participant plans to deliver within 12 weeks of study consent)
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 2 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05184907
Start Date
May 1 2022
End Date
August 2 2023
Last Update
April 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge Health Alliance
Cambridge, Massachusetts, United States, 02141